1. Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications.
- Author
-
Giannotti, Laura, Di Chiara Stanca, Benedetta, Spedicato, Francesco, Nitti, Paola, Damiano, Fabrizio, Demitri, Christian, Calabriso, Nadia, Carluccio, Maria Annunziata, Palermo, Andrea, Siculella, Luisa, and Stanca, Eleonora
- Subjects
REGENERATIVE medicine ,CLINICAL medicine ,STEM cell transplantation ,PLATELET-rich plasma ,BLOOD platelets ,AUTOTRANSPLANTATION ,PLATELET-rich fibrin - Abstract
The goal of regenerative medicine is to achieve tissue regeneration. In the past, commonly used techniques included autologous or allogeneic transplantation and stem cell therapy, which have limitations, such as a lack of donor sites in the case of autologous transplantation and the invasiveness of stem cell harvesting. In recent years, research has, therefore, focused on new and less invasive strategies to achieve tissue regeneration. A step forward in this direction has been made with the development of autologous platelet concentrates (APCs), which are derived from the patient's own blood. They can be classified into three generations: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factors (CGFs). These APCs have different structural characteristics, depending on the distinctive preparation method, and contain platelets, leukocytes, and multiple growth factors, including those most involved in regenerative processes. The purpose of this review is to clarify the most used techniques in the field of regenerative medicine in recent years, comparing the different types of APCs and analyzing the preparation protocols, the composition of the growth factors, the level of characterization achieved, and their clinical applications to date. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF